Morgan Stanley’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.6M | Buy |
5,746,226
+133,652
| +2% | +$1.29M | ﹤0.01% | 1819 |
|
|
2025
Q1 | $83.6M | Buy |
5,612,574
+1,062,407
| +23% | +$15.8M | 0.01% | 1380 |
|
|
2024
Q4 | $67.9M | Sell |
4,550,167
-568,027
| -11% | -$8.47M | ﹤0.01% | 1559 |
|
|
2024
Q3 | $97.9M | Sell |
5,118,194
-183,585
| -3% | -$3.51M | 0.01% | 1258 |
|
|
2024
Q2 | $110M | Buy |
5,301,779
+262,959
| +5% | +$5.44M | 0.01% | 1122 |
|
|
2024
Q1 | $94.7M | Sell |
5,038,820
-6,679,236
| -57% | -$126M | 0.01% | 1241 |
|
|
2023
Q4 | $169M | Buy |
11,718,056
+8,682,619
| +286% | +$125M | 0.01% | 1285 |
|
|
2023
Q3 | $52.7M | Buy |
3,035,437
+315,464
| +12% | +$5.48M | 0.01% | 1527 |
|
|
2023
Q2 | $56.6M | Buy |
2,719,973
+52,724
| +2% | +$1.1M | 0.01% | 1477 |
|
|
2023
Q1 | $62.7M | Sell |
2,667,249
-345,610
| -11% | -$8.13M | 0.01% | 1347 |
|
|
2022
Q4 | $84.1M | Sell |
3,012,859
-13,440
| -0.4% | -$375K | 0.01% | 1133 |
|
|
2022
Q3 | $70.8M | Buy |
3,026,299
+22,516
| +0.7% | +$527K | 0.01% | 1090 |
|
|
2022
Q2 | $101M | Buy |
3,003,783
+1,011,902
| +51% | +$34.2M | 0.01% | 908 |
|
|
2022
Q1 | $69.6M | Buy |
1,991,881
+138,203
| +7% | +$4.83M | 0.01% | 1080 |
|
|
2021
Q4 | $56.4M | Sell |
1,853,678
-145,572
| -7% | -$4.43M | 0.01% | 1256 |
|
|
2021
Q3 | $65.6M | Sell |
1,999,250
-65,428
| -3% | -$2.15M | 0.01% | 1113 |
|
|
2021
Q2 | $62.5M | Buy |
+2,064,678
| New | +$62.5M | 0.01% | 1154 |
|